NMPA Approval

Zoledronic Acid Concentrated Solution for Injection

Approval Number

国药准字H20244854

Company国药集团国瑞药业有限公司

Registration Date

September 10, 2024

Drug Information

Generic Name

注射用唑来膦酸浓溶液

Dosage Form

注射剂

Strength

5ml:4mg(按C₅H₁₀N₂O₇P₂计)

Drug Type

化学药品

Registration Date

September 10, 2024

Company Information

Applicant Company

Company Name国药集团国瑞药业有限公司

Company Address

安徽省淮南市经济技术开发区朝阳东路16号

Manufacturing Company

Company Name国药集团国瑞药业有限公司

Company Address

安徽省淮南市经济技术开发区朝阳东路16号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用唑来膦酸浓溶液 - NMPA 批准文号 | MedPath